Protagonist Therapeutics Inc (PTGX)
Operating Cash Flow Growth
231.79%
TTM · Period ending:
PTGX Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported231.79%period ending
Latest reported231.79%period ending
PTGX TTM Cash from Operations YoY % (-108.36% → 231.79%)
Year-over-year change
High-resolution chart · PNG
PTGX operating cash flow growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow Growth |
|---|---|
| 231.7915% | |
| -134.6155% | |
| -68.6829% | |
| -71.5715% | |
| -82.9223% | |
| 632.1457% | |
| 362.1903% | |
| 293.7962% | |
| 297.1896% | |
| 39.5924% | |
| 35.0491% | |
| -14.878% | |
| -10.0375% | |
| 10.2393% | |
| -0.2522% | |
| -3.6556% | |
| -21.8012% | |
| -36.7517% | |
| -48.8122% | |
| -46.9576% | |
| -33.0145% | |
| -109.7414% | |
| -74.5467% | |
| -81.698% | |
| -103.2682% | |
| 20.9011% | |
| 16.8579% | |
| 30.7407% | |
| -713.9412% | |
| -5,556.1538% | |
| -1,389.9535% | |
| -746.9368% | |
| 89.8813% | |
| 97.4066% | |
| 112.9187% | |
| 133.3227% | |
| -80.3071% | |
| -104.1126% | |
| -108.3559% |